JAK Inhibitor clinical trials at University of California Health
1 in progress, 0 open to eligible people
Showing trials for
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream With Phototherapy in Participants With Vitiligo
Sorry, not currently recruiting here
The purpose of this study is to evaluate the efficacy and safety of Ruxolitinib cream with or without phototherapy in adolescent and adult participants with non-segmental vitiligo for whom vitiligo area (facial and nonfacial) does not exceed 10% body surface area (BSA).
at UC Davis
Last updated: